EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹224 Cr | ₹227 Cr | ₹202 Cr | ₹178 Cr | ₹135 Cr |
What is the latest Total Liabilities ratio of EVEREST ORGANICS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹224 Cr |
| Mar2024 | ₹227 Cr |
| Mar2023 | ₹202 Cr |
| Mar2022 | ₹178 Cr |
| Mar2021 | ₹135 Cr |
How is Total Liabilities of EVEREST ORGANICS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹224 Cr | -0.94 | |
| Mar2024 | ₹227 Cr | 12.27 | |
| Mar2023 | ₹202 Cr | 13.40 | |
| Mar2022 | ₹178 Cr | 31.48 | |
| Mar2021 | ₹135 Cr | - | |
Compare Total Liabilities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹305.0 Cr | -0.7% | -7.5% | -6.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,271.0 Cr | -0.5% | -0.3% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,843.0 Cr | 3.1% | 18.9% | 33.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,000.0 Cr | -1.5% | -1.6% | 35.6% | Stock Analytics | |
| CIPLA | ₹118,072.0 Cr | -0.9% | 1.6% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,073.0 Cr | 2% | -3.8% | -0.7% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -0.7% |
-7.5% |
-6.4% |
| SENSEX | -0.8% |
0.5% |
-3.8% |
You may also like the below Video Courses